Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Gains from Sales and Divestitures: 2024

Historic Gains from Sales and Divestitures for iSpecimen (ISPC) over the last 1 years, with Dec 2024 value amounting to $1,800.

  • iSpecimen's Gains from Sales and Divestitures fell 78.08% to $382 in Q3 2025 from the same period last year, while for Sep 2025 it was $382, marking a year-over-year decrease of 78.08%. This contributed to the annual value of $1,800 for FY2024, which is N/A change from last year.
  • iSpecimen's Gains from Sales and Divestitures amounted to $1,800 in FY2024.
  • iSpecimen's Gains from Sales and Divestitures' 5-year high stood at $1,800 during FY2024, with a 5-year trough of $1,800 in FY2024.
  • In the last 1 years, iSpecimen's Gains from Sales and Divestitures had a median value of $1,800 in 2024 and averaged $1,800.